Mogamulizumab-kpkc and Orphenadrine Extended-Release Tablets
Determining the interaction of Mogamulizumab-kpkc and Orphenadrine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc-Orphenadrine Injection
- Mogamulizumab-kpkc-Orphenadrine w/A.C.
- Mogamulizumab-kpkc-Orphenadrine, aspirin, and caffeine
- Mogamulizumab-kpkc-Orphenate
- Mogamulizumab-kpkc-Orphengesic
- Mogamulizumab-kpkc-Orphengesic Forte
- Orphenadrine Extended-Release Tablets-Mogamulizumab-kpkc Intravenous
- Orphenadrine Extended-Release Tablets-Molindone
- Orphenadrine Extended-Release Tablets-Mometasone (Oral Inhalation)
- Orphenadrine Extended-Release Tablets-Mometasone and Formoterol
- Orphenadrine Extended-Release Tablets-Mometasone and formoterol Inhalation
- Orphenadrine Extended-Release Tablets-Mometasone Cream